Biotechnology.report

Biotech startup Sail Biomedicines combines Laronde and Senda Biosciences, backed by Flagship Pioneering, to pioneer a new class of fully programmable medicines. Harnessing the power of proprietary programmable payloads, nanoparticles, and AI, Sail aims to transform personalized medicine and unlock targeted, responsive therapeutics tailored to each patient's needs.

Learn more about this biotech innovation in the news: https://bit.ly/49aP9eC

Integrated DNA Technologies, a global genomics leader, opens its Therapeutic Oligonucleotide Manufacturing facility in Coralville, Iowa, signalling its entry into the therapeutics field. From research to cGMP-grade cell and gene therapy reagents, IDT serves as the one-stop partner to expedite the journey from lab to therapeutic development for researchers.

Click here to read the full article now: https://bit.ly/46CJoEB

Integrated DNA Technologies Opens New Therapeutic Manufacturing Global genomics solutions provider Integrated DNA Technologies (IDT), an operating company in the Life Sciences segment of Danaher Corporation

Ichnos Sciences has entered into an exclusive worldwide licensing agreement for its OX40 antagonist monoclonal antibody portfolio with Astria Therapeutics, Inc., a biopharmaceutical company developing therapies for rare allergic and immunological diseases.

Read the full news on the link below:
https://bit.ly/48NbkHt

Ichnos Sciences Enters Licensing Agreement For Ox40 Antagonist Ichnos Sciences, a global clinical-stage biotechnology company developing innovative multispecific antibodies for oncology

Immunic Therapeutics, a biotech company, has announced positive interim data from its phase 2 CALLIPER trial of vidofludimus calcium in patients with progressive multiple sclerosis (PMS).

Click the link below to read the full news:
https://bit.ly/46npBZS

Immunic Reports Positive Interim Data from Phase 2 CALLIPER Trial Immunic, Inc. a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic

MEDIA 7's The Biotechnology.Report cordially invites you to be a part of World Smart Bioprocessing: Pharma 4.0 Summit, set to take place in Berlin, Germany, from 27th - 29th September 2023.

Join the world technology leaders from Pharma, Biotech, and Pharma suppliers to share case studies and interactive breakouts towards commercial progress. This event is a unique opportunity to connect with global scientists, engineers, and executives working across the entire spectrum of biopharmaceutical development and production.

More details are available at: https://tinyurl.com/3xn49ywk

Featured Speakers: Bjørn Voldborg | Alice Harrison | M. Nicolas Cruz B. | Duygu Dikicioglu | Florian Schelter | Gerald Gellermann | David Ausländer | Chrysanthi Sitmalidou | Dan Bach Kristensen | Baerbel Grossmann | Peter Neubauer | Dr. Ulrich Rümenapp

Date: 27th - 29th September 2023
Physical | Cparity Event | Charles Williams

Register now: https://tinyurl.com/3xn49ywk

Smart Bioprocessing & Pharma 4.0 Summit Today’s Bioprocessing is the base of several emerging industries and technologies

Nurix Therapeutics and Seagen have joined forces to develop Degrader-Antibody Conjugates (DACs) for cancer treatment. The collaboration will combine two powerful technologies, antibody-drug conjugation (ADC) and targeted protein degradation (TPD), to create drugs with new mechanisms of action and improved anti-cancer activity.

Click the link below to read the full news:
https://bit.ly/3LmKlIK

Nurix Announces Strategic Collaboration with Seagen Combining Nurix Therapeutics, Inc. a clinical stage biopharmaceutical company developing targeted protein modulation drugs designed

Exacta BioScience and Ginkgo Bioworks, Inc. have announced a partnership to enhance one of Exacta's crop protection products, FitoRoot®, through a fermentation optimization and scale-up program.

Click the link below to read the full news:
https://tinyurl.com/5drj7tz8

Exacta Bioscience and Ginkgo Bioworks Announce Partnership Exacta Bioscience, a biotech company that harnesses the power of nature and its microorganisms for crop protection, and Ginkgo Bioworks

Watchmaker Genomics announces a multi-year agreement with Exact Sciences to develop and commercialize the breakthrough DNA methylation analysis technology, TET-assisted pyridine borane sequencing (TAPS), for advanced applications including cancer screening and minimal residual disease (MRD) testing.

Click the link below to read the full news:
https://tinyurl.com/5668f7ws

Watchmaker Genomics Announces Co-Exclusive License to Disruptive Watchmaker Genomics, a supplier of innovative products for molecular analysis, today announced a multi-year, co-exclusive agreement with Exact

NKGen Biotech, Inc. has achieved a significant breakthrough in biotechnology. The first patient has been dosed in their groundbreaking Phase I clinical trial, marking a crucial step forward in the development of innovative NK cell therapies.

Click the link below and read the full news:
https://tinyurl.com/4dnjwkwc

NKGen Biotech, Inc. Announces First Patient Dosed in Phase NKGen Biotech, Inc. a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic

Aspen Neuroscience, Inc. teams up with Emerald Innovations and Rune Labs to introduce groundbreaking digital health modalities into the Trial-Ready Screening Cohort Study.

Dive into the full news to get an in-depth look at this groundbreaking endeavor:
https://tinyurl.com/mr2mfu93

Synthego Corporation, the pioneering force behind industrialized genome editing solutions, and bit.bio, the visionary cell coding company, have united to create a groundbreaking platform that's set to reshape the future of medicine.

Dive into the full news and get ahead of the curve:
https://tinyurl.com/34bercuu

Vial, the leading tech-driven CRO in clinical trial management, is joining forces with Documenso, Inc., the open-source digital signing platform, to reshape how we handle documents in the life science sector.

Dive into the full news to discover how this collaboration is reshaping the game:
https://tinyurl.com/28sf5zde

Vial Announces Strategic Partnership to Build CFR Part 11 Open Vial, a global tech-driven CRO providing next-generation clinical trial management services, has announced a partnership with Documenso,